La Alianza para la Vacunación Infantil de la Fundación ”la Caixa” ha conseguido inmunizar a 289.825 niños y niñas especialmente vulnerables de África y Latinoamérica gracias a la solidaridad...
Read moreThe recent study, published in the Journal of Clinical Investigation Insight (JCI Insight), sheds light on how Factor inhibiting HIF (FIH), a molecule that controls cellular adaptation to hypoxia, pla...
Read moreThermo Fisher Scientific today announced a companion diagnostic (CDx) partnership with Boehringer Ingelheim. Through this collaboration, the companies will work to develop CDx tests to help identify p...
Read moreLos resultados mostraron que el tratamiento continuo con azitromicina reduce significativamente el número y la gravedad de las exacerbaciones, mejora el intercambio de gases y disminuye la respuesta ...
Read moreMore people with non-small cell lung cancer (NSCLC) are likely to benefit from new drugs that target molecular alterations in tumor cells, with less need for chemotherapy, following results of multipl...
Read moreThe main objective of the project is to optimize the treatment with tumor-infiltrating lymphocyte adoptive cell therapy (TIL-ACT) of patients with melanoma, lung cancer, or cervical cancer. and substa...
Read moreIn a phase II trial the drug tarlatamab "showed antitumor activity with durable objective responses and promising survival outcomes", researchers write in `The New England Journal of Medicine´.
Read moreUn estudio del CSIC muestra que durante la evolución tanto los genes únicos como las redes genéticas de un órgano se pueden reutilizar en otro con una función diferente
Read moreAn interdisciplinary team from the Autonomous University of Madrid (UAM) has revealed how the human rhinovirus, which causes the common cold, releases its genetic content. The results could open the d...
Read moreA study analyses the association between ambient temperature and hospital mortality from respiratory diseases in the provinces of Madrid and Barcelona
Read moreEl proyecto, que cumple 15 años de actividad, ha permitido vacunar a aproximadamente nueve millones de niños contra la neumonía, principal causa global de mortalidad infantil, y protegerles de enfe...
Read moreLa fundación apoya trabajos que luchan contra el melanoma, el mieloma múltiple y el cáncer de pulmón, de ovario y de riñón
Read more